Letter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy?
Letter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy?
复制标题
来信：哪些乙型肝炎病毒相关性肝细胞癌患者应该接受核（酸）类似物治疗？
DOI：
10.1111/apt.13773
复制
发表时间：
2016
影响因子：
7.6
通讯作者：
Peng N F
中科院分区：
文献类型：
--
作者：
Liao Y Y;Ahir B K;Mo H Y;Li L Q;Peng N F
针对GL Wong及其同事在2016年发表的关于口服核苷（酸）类似物治疗B肝炎病毒相关肝细胞癌（HCC）患者的疗效的研究，向编辑提交了一封信。
A letter to the editor is presented in response to the study regarding the efficacy of oral nucleos (t) ide analogue therapy in patients with hepatitis B virus-related hepatocellular carcinoma (HCC) by GL Wong and colleagues in the 2016 issue.